Physician profile
Stephanie E Kracker
NPI 1316379431
$2,394.09
in general payments reported to CMS, 2019-2025
29 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $621 · 2022: $426 · 2023: $605 · 2024: $528 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Travel and Lodging: $262 · Education: $82.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.59 |
| Travel and Lodging | $262.23 |
| Education | $82.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $540.05 | 2021-2024 | Myrbetriq, Xtandi |
| Intuitive Surgical, INC. | $318.18 | 2024-2025 | |
| Convatec INC. | $169.58 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $154.17 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $128.54 | 2021-2024 | |
| Dendreon Pharmaceuticals LLC | $107.89 | 2021-2025 | Provenge |
| Abbvie INC. | $106.60 | 2022-2024 | |
| Myovant Sciences INC. | $106.01 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $101.79 | 2021-2023 | Xiaflex, Aveed |
| Coloplast Corp | $83.06 | 2021-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $65.98 | 2021-2023 | Welireg, Keytruda, Lynparza |
| Axonics, INC. | $64.62 | 2021-2022 | |
| Antares Pharma, INC. | $49.57 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Progenics Pharmaceuticals, INC. | $43.38 | 2023 | Pylarify |
| Janssen Biotech, INC. | $37.87 | 2022-2024 | Akeega, Erleada |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $32.64 | 2022-2023 | Seglentis |
| Hollister Incorporated | $29.23 | 2023 | Vapro Pocket, Vapro Plus Pocket, Infyna Chic |
| Boston Scientific Corporation | $28.37 | 2022-2025 | Axonics |
| Procept Biorobotics Corporation | $28.02 | 2023 | Aquabeam Robotic System |
| 180 Medical, INC. | $26.81 | 2022 | |
| Clarus Therapeutics INC. | $26.02 | 2021 | |
| Telix Pharmaceuticals | $25.56 | 2023 | Illuccix |
| Urogen Pharma, INC. | $24.96 | 2021-2022 | |
| Teleflex LLC | $18.75 | 2021 | |
| Medtronic, INC. | $17.33 | 2024 | Interstim |
| Accord Healthcare, INC. | $17.30 | 2022 | |
| Tolmar, INC. | $16.45 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $13.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Kracker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.